Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
about
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityFirst phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacyLong-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west UgandaTopical microbicides for prevention of sexually transmitted infectionsRandomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future.Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replicationBlocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responsesAdvances in HIV microbicide developmentMicrobicides and their potential as a catalyst for multipurpose sexual and reproductive health technologiesNew candidate biomarkers in the female genital tract to evaluate microbicide toxicityNew Biomedical Technologies and Strategies for Prevention of HIV and Other Sexually Transmitted InfectionsAdherence in the CAPRISA 004 tenofovir gel microbicide trialStampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDSIn vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicideLignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmissionRectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized micePolyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infectionDevelopment of HIV-1 rectal-specific microbicides and colonic tissue evaluationExpression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral DrugsPostcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trialsStructure activity relationship of dendrimer microbicides with dual action antiviral activityWomen and HIV in Sub-Saharan Africa.HIV-prevention science at a crossroads: advances in reducing sexual risk.HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities.Nanotechnology and HIV: potential applications for treatment and prevention.Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.Overview of microbicides for the prevention of human immunodeficiency virus.The importance of the vaginal delivery route for antiretrovirals in HIV prevention.Why primate models matter.Controlling the HIV/AIDS epidemic: current status and global challengesEfficacy dilution in randomized placebo-controlled vaginal microbicide trialsAdherence and its measurement in phase 2/3 microbicide trials.Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India).The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trialEffectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria.Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plantsIntravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis.Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
P2860
Q21133918-B66835A8-D6F6-40C4-889D-213FC82E1D40Q21135264-2771AEFB-10EE-4421-946E-706D6781CBECQ21203732-8E960381-F3A4-4BAE-93FF-ED02803CE97EQ24202832-3ED96688-C80E-401E-B33E-0FF010F3C8B3Q24600011-F7BE8BF0-7BC5-4F31-8ED0-FB4290CBC9F3Q24634299-985C4D7B-6F03-45B6-8735-117E1CBB3039Q26774878-831CE19F-BD26-4ECC-BCAA-F3A04E8D6C6EQ26852858-8F3A1ABB-E208-47FE-93F9-4E0755CC269EQ27026257-65E45B4C-C388-4D70-84E8-4F99296B7A71Q27334382-31C19877-E021-4868-B833-8E2854CCFD68Q28072213-5E2B0D1A-D1D4-425B-BD74-DAC38ABB7057Q28236148-28CF62C9-C804-42E6-BBA6-F4D06512CFD0Q28260539-198F4173-5F7B-4471-9912-EC93643D373AQ28472968-CDE25D87-85D6-406C-952A-51773A9A10A0Q28482818-D1462AF9-C916-47E0-A7B7-1A87B8AA9963Q28488527-5272B9E4-5124-44AF-96BF-C6EBB0C44575Q28489042-74D6D0B6-1D13-4621-A69E-0D135D8126CDQ28540761-8FA7A36F-D8F3-4C0C-A66F-D322C508800EQ28548592-EB6892FF-8965-479D-90E9-A122A64F5767Q28749211-30F4C51D-AFC5-4313-A5B8-7BA26C3D8574Q28749596-3ED3FDD9-5AFE-4353-BCE1-BE4EA2A55147Q30356708-DE175804-1489-46C7-87F6-046960D3D159Q30378142-299C9ED9-97E9-4C1E-8463-7EEB5D000964Q30383181-D946E41B-2CE4-4FB8-8D58-F754FD399D95Q30393980-A705389C-E240-4327-BA75-006947AF9C25Q30412592-5637703F-45B0-4388-A974-8DFE34F4A165Q30413777-F9B75DE4-9E9B-4159-B84E-F833710B87ABQ30414890-E6D2D15C-FC45-4530-A139-6098CBA85990Q30417520-852B8886-8A78-4EC8-9E37-A339158F2DDBQ30420558-47797F8F-78FE-453A-B93C-E0345E7890F3Q30491264-299FA0E6-260D-49E6-9693-654DB1EC80EAQ30496720-138D6424-1966-4398-824A-DEECC252FCE5Q30499386-13B9C6E1-AC31-428D-BAC8-5F874B508082Q30499941-D46F9A94-472F-45FF-848F-392AC9340A57Q30828147-34A44106-E9E4-4707-9E3E-CB894C4327CCQ33378486-9E50BA65-74B6-4B25-B8C7-1649108B80BCQ33386027-C7B6B245-D016-4953-9070-E2C440CE0731Q33490833-502A1AAC-492A-49E7-B835-DF12FD0D5BF3Q33531770-6CA86089-3F50-4432-9359-A15E7FF74DD6Q33581944-DB87F0BA-6BDF-4666-8716-06C31F2D41AE
P2860
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lack of effectiveness of cellu ...... n of vaginal HIV transmission.
@en
Lack of effectiveness of cellu ...... n of vaginal HIV transmission.
@nl
type
label
Lack of effectiveness of cellu ...... n of vaginal HIV transmission.
@en
Lack of effectiveness of cellu ...... n of vaginal HIV transmission.
@nl
prefLabel
Lack of effectiveness of cellu ...... n of vaginal HIV transmission.
@en
Lack of effectiveness of cellu ...... n of vaginal HIV transmission.
@nl
P2093
P50
P921
P356
P1476
Lack of effectiveness of cellu ...... n of vaginal HIV transmission.
@en
P2093
A K Krishnan
B S Pradeep
Bina Pande
CS Study Group
Doug Taylor
Fernand Guédou
Florence M Mirembe
Jennifer Deese
Lut Van Damme
Michel Alary
P304
P356
10.1056/NEJMOA0707957
P407
P577
2008-07-01T00:00:00Z